The 23rd Congress of the European Hematology Association (EHA) 2018, took place on the 14–17 June in Stockholm, Sweden. EHA 2018 brought together leading experts in hematological oncology from around the world, who presented the latest updates in key areas.
Highlights in hematological oncology from this year’s conference include promising results from many clinical trials, including DESTINY and CAPTIVATE, advances in the use of biomarkers to detect disease and inform treatment strategy, and the latest applications of immunotherapy.
By choosing to continue, you are confirming that you are a healthcare professional
Keep up to date with all the latest news with our monthly newsletter